Tags

Type your tag names separated by a space and hit enter

Are there clinically significant differences between dopamine agonists.
Adv Neurol. 2003; 91:259-66.AN

Authors+Show Affiliations

Stocchi F
Institute of Neurology IRCCS Neuromed (Is), University La Sapienza, Rome, Italy.
Vacca L
No affiliation info available
Onofrj M
No affiliation info available

MeSH

Antiparkinson AgentsClinical Trials as TopicDisorders of Excessive SomnolenceDopamine AgonistsDyskinesia, Drug-InducedHumansLevodopaParkinson DiseaseReceptors, Dopamine

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

12442684

Citation

Stocchi, Fabrizio, et al. "Are There Clinically Significant Differences Between Dopamine Agonists." Advances in Neurology, vol. 91, 2003, pp. 259-66.
Stocchi F, Vacca L, Onofrj M. Are there clinically significant differences between dopamine agonists. Adv Neurol. 2003;91:259-66.
Stocchi, F., Vacca, L., & Onofrj, M. (2003). Are there clinically significant differences between dopamine agonists. Advances in Neurology, 91, 259-66.
Stocchi F, Vacca L, Onofrj M. Are There Clinically Significant Differences Between Dopamine Agonists. Adv Neurol. 2003;91:259-66. PubMed PMID: 12442684.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Are there clinically significant differences between dopamine agonists. AU - Stocchi,Fabrizio, AU - Vacca,Laura, AU - Onofrj,Marco, PY - 2002/11/22/pubmed PY - 2003/1/8/medline PY - 2002/11/22/entrez SP - 259 EP - 66 JF - Advances in neurology JO - Adv Neurol VL - 91 SN - 0091-3952 UR - https://www.unboundmedicine.com/medline/citation/12442684/Are_there_clinically_significant_differences_between_dopamine_agonists_ DB - PRIME DP - Unbound Medicine ER -